Pregabalin recall in Canada: May contain partially full or empty capsules
In plain language
This recall involves Pregabalin capsules sold in Canada. It's being recalled because some capsules may be partially full or empty, which could affect the medication's effectiveness. Consult your healthcare provider before stopping use and follow the return steps in the official notice.
What to do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use.
- Contact the recalling firm if you have questions.
- Report any health product related side effects to Health Canada.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
PREGABALIN 50MG Capsule
Lot: 652628
Why this matters
Product quality issue affecting medication effectiveness
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the lot number
Lot numbers identify specific production batches.
Affected lots: 652628
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Product quality issue affecting medication effectiveness
What should consumers do?
Verify if your product is affected. Consult your healthcare provider prior to discontinuing use. Contact the recalling firm if you have questions. Report any health product related side effects to Health Canada.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Product quality issue affecting medication effectiveness
When was this product recalled?
This product was recalled on November 19, 2024.
Is the PREGABALIN brand affected by this recall?
Yes, PREGABALIN products are affected by this recall. This recall involves Pregabalin capsules sold in Canada. It's being recalled because some capsules may be partially full or empty, which could affect the medication's effectiveness. Consult your healthcare provider before stopping use and follow the return steps in the official notice.